Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

NSCLC Case Links Dual EGFR/MET Therapy to Phlegmasia Cerulea Dolens

NIH case report describes phlegmasia cerulea dolens and pulmonary embolism in an NSCLC patient receiving dual EGFR/MET targeted therapy.

ENT1 dimerization driven by ASMase and ceramide platforms increased gemcitabine uptake in sarcoma models and produced early durable…

The scraped source includes only the title and metadata, not the article body needed for an accurate clinical…

A 2025 review outlines how multi-cancer early detection tests may identify tumors from one blood sample, while warning…

A 2024 review examines ES-SCLC standard care, emerging molecular subtypes, and the biologic reasons why new therapies remain…

A Biochimie review outlines how sphingolipid metabolism may fuel lung cancer resistance to chemotherapy, radiotherapy, and immunotherapy.

Uterine cancer received far less Department of Defense research funding than colorectal cancer despite a high and rising…

Spanish-language inquiries to the NCI Cancer Information Service centered on staging, treatment, and common cancers, with LiveHelp used…

UK regulator approves catumaxomab for malignant ascites in adults when standard cancer treatment is no longer feasible, citing…

The Royal Marsden Centre for Cancer Genomics launches composite biomarker testing to build AI-guided tumour profiles for personalised…

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds